DEA Selects Only Cannabis Opponents For Crucial June 29 Rescheduling Hearing
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyMental HealthPainAnxietyIndustry Why This Matters # ResponseClinicians need to understand that the…
Review Finds Just 31% of Consumer CBD Products Meet Label-Accuracy Standard
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDSafetyIndustryResearchPolicyHempDosing Why This Matters Clinicians prescribing or recommending CBD to patients face a…
How Medical Marijuana Recommendations Expand Care
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyPainAnxietyMental HealthSafetyIndustryResearch Why This Matters Clinicians need to understand their role in the…
Ohio Tax Department Amends Adult-Use Cannabis Tax Rules
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearchSafetyHempTHCCBD Why This Matters Ohio’s tax amendments directly affect the cost and…
States Surpass $28 Billion in Tax Revenue From Legal Adult-Use Cannabis Sales
✦ New CED Clinical Relevance #42 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearchSafetyMental HealthAgingHemp Why This Matters Cannabis tax revenue data is clinically relevant…
DEA Begins On-Site Inspections at Marijuana Businesses Seeking Federal Compliance
DEA cannabis inspections product safety initiatives mark a key step in establishing consistent quality standards for marijuana businesses. These inspections improve product consistency and reduce contamination risks for patients. Clinicians can better…
What’s in your weed? Study finds issues with labelling, tracking cannabis
✦ New CED Clinical Relevance #50 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyIndustryTHCCBDDosing Why This Matters Clinicians need accurate product labeling and composition data…
Only 1 in 3 Older Adults Screened for Cannabis, Drug Use
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. AgingResearchSafetyPolicyMental HealthAnxietyPain Why This Matters Clinicians miss opportunities to identify substance…
7 unexpected takeaways from the newest research on cannabis and brain effects
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchMental HealthNeurologyTHCCBDSafetyPolicy Clinical Summary Recent research on cannabis and neurobiological…
One Scientist’s War To Understand Unregulated Drugs
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchHempSafetyPolicyIndustryPainAnxiety Why This Matters Clinicians need standardized cannabis testing data to…